Parmax Pharma

quarterly
yearly
ParticularsJun '24Sep '24Dec '24Mar '25Jun '25
Revenue7.839.406.294.731.95
Expenses7.819.616.705.452.71
EBITDA0.520.310.12-0.67-0.24
EBIT0.12-0.09-0.28-1.56-0.48
Profit Before Tax0.01-0.22-0.39-1.79-0.76
Net Profit0.01-0.22-0.39-1.49-0.76
Financial Ratios
Operating Profit Margin6.65%3.45%1.91%-36.02%-12.37%
Net Profit Margin0.13%-2.37%-6.21%-8.70%-39.18%
Earning Per Share (Diluted)0.03-0.58-1.05-4.00-2.04
Dividends Per Share0.000.000.000.000.00